Skip to main content

Advertisement

Log in

Poly-ADP-ribosylation in health and disease

Regulation of poly(ADP-ribose) metabolism by poly(ADP-ribose) glycohydrolase: where and when?

  • Multi-author Review
  • Published:
Cellular and Molecular Life Sciences CMLS Aims and scope Submit manuscript

Abstract.

Poly(ADP-ribose) glycohydrolase (PARG) is a catabolic enzyme that cleaves ADP-ribose polymers formed by members of the PARP family of enzymes. Despite its discovery and subsequent partial purification in the 1970s [1–3] and the cloning of its single gene in the late 1990s [4], little is known about the role of PARG in cell function. Because of its low abundance within cells and its extreme sensitivity to proteases, PARG has been difficult to study. The existence of several PARG isoforms with different subcellular localizations is still debated today after more than 30 years of intensive research. In this article, we want to summarize and discuss the current knowledge related to PARG, its different forms and subcellular distribution. We also examine the possible biological roles of PARG in modulating chromatin structure, transcription, DNA repair and apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. G. Poirier.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bonicalzi, ME., Haince, JF., Droit, A. et al. Poly-ADP-ribosylation in health and disease. CMLS, Cell. Mol. Life Sci. 62, 739–750 (2005). https://doi.org/10.1007/s00018-004-4505-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-004-4505-1

Key words.

Navigation